Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Assets Average: 2020-2025

Historic Assets Average for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $1.2 billion.

  • Harmony Biosciences Holdings' Assets Average rose 29.65% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 29.65%. This contributed to the annual value of $905.3 million for FY2024, which is 21.90% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Assets Average stood at $1.2 billion, which was up 7.06% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Assets Average ranged from a high of $1.2 billion in Q3 2025 and a low of $348.5 million during Q2 2021.
  • Its 3-year average for Assets Average is $891.1 million, with a median of $852.7 million in 2024.
  • Data for Harmony Biosciences Holdings' Assets Average shows a peak YoY soared of 59.77% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Harmony Biosciences Holdings' Assets Average stood at $412.3 million in 2021, then surged by 59.77% to $658.7 million in 2022, then increased by 20.64% to $794.6 million in 2023, then grew by 21.28% to $963.7 million in 2024, then rose by 29.65% to $1.2 billion in 2025.
  • Its Assets Average was $1.2 billion in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.0 billion in Q1 2025.